An assessment of the effectiveness of Andolex-C ® mouth rinse on oral palliation in HIV-infected patients

Date
2008-11-04T12:34:12Z
Authors
Malele, Yolanda
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Title: An assessment of the effectiveness of Andolex-C ® mouth rinse on oral palliation in HIV-infected patients. Background: The majority of HIV-infected patients present with oral lesions associated with the disease. HIV-infected patients experience profound disorders like oral infections and ulcerations, discomfort and greater levels of social impact than non-HIV patients as a result of oral lesions. Studies have indicated that mouth pain is a significant symptom reported by HIV-infected patients. In order to relieve pain and discomfort and improve quality of life, management of HIV-infected patients should include relief of mouth pain, discomfort as well as the social and psychological distress caused by the oral lesions. Objectives: To determine the prevalence of oral lesions associated with HIV among a cohort of HIV-infected patients. To assess the effectiveness of Andolex-C® mouth rinse on oral palliation in HIV-infected patients. Methods: The intervention of Andolex C® mouth rinse plus a proven preventive oral hygiene regimen was compared to an established oral hygiene intervention. Two hundred and ninety nine patients were randomly assigned into Groups 1 and 2. Patients in Group 1 were given toothbrushes and toothpaste and oral hygiene instruction ‘routine oral hygiene package’. Those in Group 2 received Andolex-C® mouth rinse in addition to the ‘routine oral hygiene package’ given to the first group. A baseline assessment of mouth pain and/or discomfort was done via a clinical examination and an assessment of quality of life was done using the Oral Health Impact Profile (OHIP) questionnaire. The intervention was carried out over a four week period after which a follow-up assessment was done using the same tools. Comparison of baseline versus post-treatment scores was performed to determine impact of intervention in both groups. Results: The prevalence of combined candidal lesions was 71.6% of which Pseudomembranous candidiasis was 43.2%. Erythematous candidiasis and angular cheilitis were the next commonly seen, each with an equal prevalence of 14.2 %. Group 2 (Andolex-C® mouth rinse) showed a statistically significant improvement in quality of life on all subscales related to functioning, pain, psychological and social aspects when using the OHIP index. The patients demonstrated substantial reduction of [64%] of mouth pain and/or discomfort and a 73% reduction of oral lesions compared to Group 1 where there was a much smaller [22%] reduction of mouth pain and/or discomfort and a 40% reduction of the oral lesions. Conclusion: Andolex-C® mouth rinse improved the quality of life of HIV-infected patients who presented with mouth pain and/or discomfort and demonstrated that in combination with proper oral care and good hygiene habits, this regimen could be recommended for oral palliation in HIV positive patients.
Description
Keywords
oral palliation, Benzydamine and Chlorhexidine mouth rinse, Oral HIV
Citation
Collections